Optical computing has emerged as a powerful approach for high-speed and energy-efficient information processing. Diffractive ...

The U.S. Army is formalizing a new career path that allows officers to specialize in artificial intelligence and machine ...

Since 2021, Korean researchers have been providing a simple software development framework to users with relatively limited ...

University of Idaho receives over $6M in DoD grants to advance machine learning research for PTSD diagnosis and military ...

Applied Digital Corp (NASDAQ: APLD) shares are trending on Monday. Here’s a look at what you need to know. What To Know: Applied Digital has shifted its primary focus from hosting Bitcoin mining ...

Applied Materials has seen its fair value estimate tick up to $248.44 from $241.69 as analysts grow more confident in the durability of the wafer fab equipment upcycle and the company’s strong recent ...

Applied Therapeutics ( (APLT)) has shared an update. On December 11, 2025, Applied Therapeutics announced a merger agreement with Cycle Group Holdings Limited, where Cycle will acquire all outstanding ...

Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.

(RTTNews) - Applied Therapeutics Inc. (APLT), a clinical-stage biopharmaceutical company focused on rare metabolic diseases, has agreed to be acquired by privately held Cycle Group Holdings Ltd. The ...

Investing.com - RBC Capital lowered its price target on Applied Therapeutics (NASDAQ:APLT) to $0.25 from $1.00 while maintaining a Sector Perform rating. The stock currently trades at $0.22, down 86% ...

Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases NEW YORK, Dec. 11, 2025 ...